Evidence map›Paper›PMID 26849888›Full record

SynthesisBMC neurology2016

Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients.

Ekokobe Fonkem, Samantha Dayawansa, Edana Stroberg, Edwin Lok, Paul C Bricker, Batool Kirmani, Eric T Wong, Jason H Huang

Abstract readMeta-Analysis
In one paragraph

Synthesis in BMC neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Review
  2. Article
  3. Case Report: Neuropsychological Profile of a Patient With Intravascular Large B-Cell Lymphoma Following Infection and Vaccination.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Article
  4. MR findings of intravascular large B-cell lymphoma of the central nervous system: report of three cases.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ekokobe FonkemDepartment of Neurosurgery, Baylor Scott & White Health, Temple, Texas, 76508, USA. efonkem@sw.org.
Samantha DayawansaDepartment of Neurosurgery, Baylor Scott & White Health, Temple, Texas, 76508, USA. sdayawansa@sw.org.
Edana StrobergDepartment of Pathology, Baylor Scott & White Health, Temple, Texas, 76508, USA. estroberg@sw.org.
Edwin LokDepartment of Neurology, Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, Massachusetts, 02215, USA. elok@bidmc.harvard.edu.
Paul C BrickerDepartment of Neurology, Baylor Scott & White Health, Temple, Texas, 76508, USA. pbricker@sw.org.
Batool KirmaniDepartment of Neurology, Baylor Scott & White Health, Temple, Texas, 76508, USA. Bkimani@sw.org.
Eric T WongDepartment of Neurology, Brain Tumor Center and Neuro-Oncology Unit, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, Massachusetts, 02215, USA. ewong@bidmc.harvard.edu.
Jason H HuangDepartment of Neurosurgery, Baylor Scott & White Health, Temple, Texas, 76508, USA. jhuang@sw.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with intravascular lymphoma (IVL) frequently have neurological signs and symptoms. Prompt diagnosis and treatment is therefore crucial for their survival. However, the spectrum of neurological presentations and their respective frequencies have not been adequately characterized. Our aim is to document the spectrum of clinical symptoms and their respective frequencies and to create a clinical framework for the prompt diagnosis of IVL.

methodsA comprehensive meta-analysis of 654 cases of IVL published between 1957 and 2012 was performed to provide better insight into the neurological presentations of this disease. Neurologic complications were mainly divided into central nervous system (CNS) and peripheral nervous system (PNS) presentations.

resultsThere were no differences in occurrences of CNS IVL based on gender or geographic locations (Asian Vs non-Asian). However, most patients with CNS IVL were younger than 70 years of age (p < 0.05). Our limited data do not support the treatment efficacy of methotrexate. CNS symptoms were seen in 42% of all cases. The most common CNS complications identified were cognitive impairment/dementia (60.9%), paralysis (22.2%), and seizures (13.4%). PNS complications were seen in 9.5% of cases. Out of these, muscle weakness (59.7%), neurogenic bladder (37.1%), and paresthesia (16.1%) were the most common presentations.

conclusionsCNS complications are more common among IVL patients. Out of these, dementia and seizures outnumber stroke-like presentations.

Indexed as

AdolescentAdultAgedAged, 80 and overCentral Nervous System DiseasesFemaleHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedPeripheral Nervous System DiseasesVascular NeoplasmsYoung Adult

Identifiers

PMID26849888
PMCPMC4744383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.